Overview
Research conducted at the Perelman School of Medicine at the University of Pennsylvania indicates that proteins traditionally associated with neurodegenerative diseases, specifically prions and prion-like proteins, may harbor short peptides with antibacterial capabilities. These peptides, referred to as 'prionins,' are suggested as potential new antibiotic candidates against drug-resistant bacteria.
Research Context
Prion proteins are known for their role in rare and fatal degenerative brain diseases due to misfolding. The current investigation explores an unexpected facet of these proteins, suggesting they may contain molecular features linked to immune defense mechanisms. This expands the understanding of prions beyond their established neurodegenerative associations.
Findings
- Prion and prion-like proteins are observed to contain short peptides, designated as prionins.
- These prionins demonstrate the ability to kill bacteria.
- The findings suggest that proteins recognized for their involvement in neurodegeneration may also possess molecular characteristics associated with immune defense.
- The identification of these potential antibiotic candidates involved the use of Artificial Intelligence (AI).
Why This Matters
The identification of prionins represents a novel source for antibiotic candidates, which is particularly relevant in the context of drug-resistant bacteria. This research redirects attention to a protein class previously primarily associated with disease, suggesting a broader biological function tied to immune defense.